ADDovenom: Novel Snakebite Therapy Platform of Unparalleled Efficacy, Safety and Affordabillity

About ADDovenom

Snakebites can be life-threatening when venom toxins are injected and enter the bloodstream. In areas where immediate access to specialised medical care is limited, bites by venomous snakes cause many thousands of deaths each year.

The EU-funded ADDovenom Project will use an innovative platform enabling generation of new snakebite treatment, based on a new disruptive protein-based nanoscaffold called ADDomer© – a megadalton- sized, thermostable synthetic virus-like particle with 60 high-affinity binding sites to neutralise and eliminate venom toxins from the bloodstream.

ADDovenom combines pioneering proteomics, transcriptomics and bioinformatics focusing on snake toxins provoking the most challenging syndromes like haemorrhage and paralysis. The aim is to develop first-in-class neutralising superbinders for snakebite therapy of unprecedented efficacy against the most prevalent Sub-Saharan snakes.

ADDomer©: Synthetic multiepitope display scaffold for next generation vaccines.


The project comprises several technological challenges (rational design of new antigens as consensus toxins/epitope strings, design of an ADDobody library) and high-risk
research (in vitro selection of new binders from a novel protein scaffold).

Mass spectrometry
to analyse venoms

Liège -LSTM

In vitro evolution
characterization of
ADDobody binders

UoB - Liège - AMU

Examination of neutralizing ability of selected ADDobodies
and gigabodies


Scalable bioprocess
gigabody production

UoB - Liège

Latest News

Researcher Spotlight: Becky Edge

For our Researcher Spotlight features, we interview members of the ADDovenom research team, to find out about their interests, their contributions to the project, and their hopes for the future

Read More »

JOB VACANCY: Research Assistant, LSTM

Would you like to join our international, multi-disciplinary team of researchers who are dedicated to developing novel protein-based snakebite treatments? The Centre for Snakebite Research and Interventions (CSRI) at the

Read More »

EVENT: Venoms – Drugs and Antidotes

ADDovenom researcher Nick Casewell (Liverpool School of Tropical Medicine) will be one of the speakers for the Academic Drug Discovery Consortium‘s latest ‘Things You Need To Know’ webinar which takes

Read More »

Snakebite antivenoms step into the future

ADDovenom researchers Nick Casewell and Robert Harrison, from Liverpool School of Tropical Medicine, have been interviewed for an article published by the Drug Discovery Network.  Written by Stephanie DeMarco and published

Read More »


ADDovenom synergistically combines unique expertise across a range of techniques and scientific disciplines, towards the objective to develop easy to produce, first-in-class neutralizing superbinders for snakebite therapy.